Abstract
Occidiofungin is a cyclic glyco-lipopeptide produced by Burkholderia contaminans. MICs against Candida species were between 0.5 and 2.0 μg/ml. Occidiofungin retains its in vitro potency in the presence of 5% and 50% human serum with a minimal lethal concentration (MLC) of 2 and 4 μg/ml, respectively. Time-kill and postantifungal effect (PAFE) experiments of occidiofungin against Candida albicans were performed. The results demonstrate that occidiofungin is fungicidal. Occidiofungin was also found to be a very stable molecule. It is resistant to extreme temperatures and pH and maintains its activity following exposure to gastric proteases. Copyright © 2012, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Ellis, D., Gosai, J., Emrick, C., Heintz, R., Romans, L., Gordon, D., … Smith, L. (2012). Occidiofungin’s chemical stability and in vitro potency against Candida species. Antimicrobial Agents and Chemotherapy, 56(2), 765–769. https://doi.org/10.1128/AAC.05231-11
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.